Skip to content

Validation of Physical Activity Scale for the Elderly (PASE) in Stroke Patients

Validation of Physical Activity Scale for the Elderly (PASE) in Stroke Patients: Relationship Between PASE and Physical Activity Measured by Portable Accelerometer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04092322
Enrollment
25
Registered
2019-09-17
Start date
2019-09-25
Completion date
2019-11-25
Last updated
2019-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

stroke, physical activity, accelerometer, physical activity scale for elderly

Brief summary

The Physical Activity Scale for the Elderly (PASE) is a self-report questionnaire on exercise, home, and work-related physical activities performed during the last week. PASE has shown to be reliable and valid in different populations of people between 65 and 100 years of age and after stroke. However, its validation on stroke was based on another self report questionnaire that assess physical activity called ''Senior Fitness Test''. Since accelerometers are more objective methods to assess PA, to the best of our knowledge, self-report physical activity questionnaires should be validated based on accelerometer derived physical activity data. The aim of this study is to validate PASE in patients with stroke based on accelerometer data.

Detailed description

The Physical Activity Scale for the Elderly (PASE) is a self-report questionnaire on exercise, home, and work-related physical activities performed during the last week. PASE has shown to be reliable and valid in different populations of people between 65 and 100 years of age and after stroke. However, its validation on stroke was based on another self report questionnaire that assess physical activity (PA) called ''Senior Fitness Test''. There are four methods to measure physical activity: 1. Self-Report Questionnaires 2.Self-Report Activity Diaries/Logs 3.Direct Observation 4. Devices (Accelerometers, pedometers, arm band, Heart-Rate Monitors). Accelerometers can measure PA accurately and have ability capture large amounts of data. Accelerometers measure acceleration (activity counts:AC) in real time and detect movement in up to three orthogonal planes (anteroposterior, mediolateral, and vertical) These counts are then translated into a metric of interest, which can be biological (e.g. energy expenditure) or PA patterns (e.g. stationary). There are pros and cons of measurement methods of physical activity. Strengths of accelerometers include minute-by-minute on-line monitoring, capturing intensity level. Accumulated AC provide an accurate estimate of the duration and intensity of body movement at the waist and were summed across the whole day to assess total PA volume. However, accelerometers are expensive and require technical expertise, specialized hardware, software, and individual programming. Self-report PA measurement methods are able to measure large numbers of participants at low cost. Since accelerometers are more objective methods to assess PA, to the best of our knowledge, self-report physical activity questionnaires should be validated based on accelerometer derived physical activity data. The aim of this study is to validate PASE in patients with stroke based on accelerometer data.

Interventions

DEVICEActical accelerometers (Philips Respironics)

patients with stroke will be evaluated by using PASE scale and accelerometer results (accelerometer will be held from Monday to Friday

OTHERPASE

Physical Activity Scale for Elderly

Sponsors

Marmara University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Patients with first ever, unilateral stroke 2. Patients with stroke who can walk independently or with an assistive device 3. Being at between the ages of 40-80

Exclusion criteria

1. Illiteracy 2. Having severely impaired mental function and being unable to complete questionnaires 3. Presence of neglect, demantia, apraxia 4. Having uncontrolled hypertension, cardiopulmonary disease

Design outcomes

Primary

MeasureTime frameDescription
PASEDay 0Physical Activity Score for Elderly

Secondary

MeasureTime frameDescription
EE totalDay 0Total energy expenditure obtained from accelerometer
AC moderateDay 0activity counts derived from accelerometer during moderate physical activity
EE moderateDay 0energy expenditure obtained from accelerometer during moderate physical activity
AC lightDay 0activity counts derived from accelerometer during light physical activity
EE lightDay 0energy expenditure obtained from accelerometer during light physical activity
ACtotalDay 0Total activity count obtained from accelerometer
EE vigorousDay 0energy expenditure obtained from accelerometer during vigorous physical activity
AC sedentaryDay 0activity counts derived from accelerometer during sedentary physical activity
EE sedentaryDay 0energy expenditure obtained from accelerometer during sedentary physical activity
step countDay 0total step count obtained from accelerometer
Stroke Impact Scale total scoreDay 0Stroke Impact Scale is a stroke specific quality of life scale. The current version of the SIS (SIS version 3.0) is a 59-item patient-reported outcome measure, covering 8 domains: strength (4 items), hand function (5 items), mobility (9 items), activities of daily living (10 items), memory (7 items), communication (7 items), emotion (9 items), and handicap (8 items). Domains are scored on a metric of 0 to 100, with higher scores indicating better self-reported health. Four of the scales of the SIS can be combined into a composite physical domain (strength, hand function, physical and instrumental activities of daily living, and mobility), with scores also presented on a 0 to 100 metric.
AC vigorousDay 0activity counts derived from accelerometer during vigorous physical activity

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026